Stilla Technologies Secures USD22 Million Investment From Chinese Investor

February 12, 2020 11:09 pm

Beijing (PingWest)- Paris-based life science startup Stilla Technologies has secured a USD22 million from China’s Tus Holding in its series B financing round. Existing investor including Kurma Partners, LBO Finance, Paris Saclay Seed Funds, BNP Paribas Development also participate in this round.

Stilla Technologies will use the fresh capital from the round to boost the development of its genetic tests and expand its presence in Asia.

Founded in 2013 at Ecole Polytechnique, Stilla Technologies is a Paris-based European life sciences company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System.